These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29474999)

  • 61. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.
    Gorges M; Maier MN; Rosskopf J; Vintonyak O; Pinkhardt EH; Ludolph AC; Müller HP; Kassubek J
    J Neurol; 2017 Sep; 264(9):1919-1928. PubMed ID: 28762086
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
    J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies.
    Constantinescu R; Andreasson U; Holmberg B; Zetterberg H
    Acta Neurol Scand; 2013 Feb; 127(2):e8-12. PubMed ID: 22998191
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study.
    Worker A; Blain C; Jarosz J; Chaudhuri KR; Barker GJ; Williams SC; Brown RG; Leigh PN; Dell'Acqua F; Simmons A
    PLoS One; 2014; 9(11):e112638. PubMed ID: 25405990
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis.
    Levin J; Bötzel K; Giese A; Vogeser M; Lorenzl S
    Dement Geriatr Cogn Disord; 2010; 29(6):553-9. PubMed ID: 20606437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease.
    Barbiroli B; Martinelli P; Patuelli A; Lodi R; Iotti S; Cortelli P; Montagna P
    Mov Disord; 1999 May; 14(3):430-5. PubMed ID: 10348465
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Brain amino acids and glutathione in progressive supranuclear palsy.
    Perry TL; Hansen S; Jones K
    Neurology; 1988 Jun; 38(6):943-6. PubMed ID: 3368077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in the metabolic profiles of the serum and putamen in Parkinson's disease patients - In vitro and in vivo NMR spectroscopy studies.
    Toczylowska B; Zieminska E; Michałowska M; Chalimoniuk M; Fiszer U
    Brain Res; 2020 Dec; 1748():147118. PubMed ID: 32931820
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.
    Han W; Sapkota S; Camicioli R; Dixon RA; Li L
    Mov Disord; 2017 Dec; 32(12):1720-1728. PubMed ID: 28880465
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma Metabolite Markers of Parkinson's Disease and Atypical Parkinsonism.
    Pathan M; Wu J; Lakso HÅ; Forsgren L; Öhman A
    Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940618
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study.
    Picca A; Calvani R; Landi G; Marini F; Biancolillo A; Gervasoni J; Persichilli S; Primiano A; Urbani A; Bossola M; Bentivoglio AR; Cesari M; Landi F; Bernabei R; Marzetti E; Lo Monaco MR
    Exp Gerontol; 2019 Dec; 128():110766. PubMed ID: 31666195
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Longitudinal metabolomics profiling of serum amino acids in rotenone-induced Parkinson's mouse model.
    Yan Z; Yang F; Wen S; Ding W; Si Y; Li R; Wang K; Yao L
    Amino Acids; 2022 Jan; 54(1):111-121. PubMed ID: 35028704
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Search for Early Pancreatic Cancer Blood Biomarkers in Five European Prospective Population Biobanks Using Metabolomics.
    Fest J; Vijfhuizen LS; Goeman JJ; Veth O; Joensuu A; Perola M; Männistö S; Ness-Jensen E; Hveem K; Haller T; Tonisson N; Mikkel K; Metspalu A; van Duijn CM; Ikram A; Stricker BH; Ruiter R; van Eijck CHJ; van Ommen GB; ʼt Hoen PAC
    Endocrinology; 2019 Jul; 160(7):1731-1742. PubMed ID: 31125048
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of potential urine biomarkers in idiopathic parkinson's disease using NMR.
    Kumari S; Kumaran SS; Goyal V; Sharma RK; Sinha N; Dwivedi SN; Srivastava AK; Jagannathan NR
    Clin Chim Acta; 2020 Nov; 510():442-449. PubMed ID: 32791135
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study.
    Labaki WW; Gu T; Murray S; Curtis JL; Yeomans L; Bowler RP; Barr RG; Comellas AP; Hansel NN; Cooper CB; Barjaktarevic I; Kanner RE; Paine R; McDonald MN; Krishnan JA; Peters SP; Woodruff PG; O'Neal WK; Diao W; He B; Martinez FJ; Standiford TJ; Stringer KA; Han MK
    Sci Rep; 2019 Aug; 9(1):11367. PubMed ID: 31388056
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy.
    Hasim A; Ali M; Mamtimin B; Ma JQ; Li QZ; Abudula A
    Exp Ther Med; 2012 Jun; 3(6):945-951. PubMed ID: 22969997
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolomics and its application in the mechanism analysis on diabetic bone metabolic abnormality.
    Liang WD; Huang PJ; Xiong LH; Zhou S; Ye RY; Liu JR; Wei H; Lai RY
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9591-9600. PubMed ID: 33015802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson's disease patients.
    Hamid Z; Basit A; Pontis S; Piras F; Assogna F; Bossù P; Pontieri FE; Stefani A; Spalletta G; Franceschi P; Reggiani A; Armirotti A
    Metabolomics; 2019 May; 15(5):74. PubMed ID: 31053995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.